Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-009171

Options or other derivatives

  • Director acquired 20,082 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STALDER RUEDI · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-05-20 Grant or award : show line 1 in the form Common Stock Option +20,082 $0.61 2020-05-20 20,082 909,951 D
Loading xslF345X03/edgar.xml…